123 related articles for article (PubMed ID: 34242947)
1. Simultaneous quantification of abemaciclib and its active metabolites in human and mouse plasma by UHPLC-MS/MS.
Martínez-Chávez A; Tibben MM; de Jong KAM; Rosing H; Schinkel AH; Beijnen JH
J Pharm Biomed Anal; 2021 Sep; 203():114225. PubMed ID: 34242947
[TBL] [Abstract][Full Text] [Related]
2. "A new LC-MS/MS method for the simultaneous quantification of abemaciclib, its main active metabolites M2 and M20, and letrozole for therapeutic drug monitoring".
Soledad Poetto A; Posocco B; Zanchetta M; Gagno S; Orleni M; Canil G; Alberti M; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Sep; 1207():123403. PubMed ID: 35940043
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic drug monitoring in breast cancer therapy - LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serum.
Habler K; Kalla AS; Rychlik M; Vogeser M; Teupser D
J Pharm Biomed Anal; 2023 Feb; 225():115211. PubMed ID: 36603395
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a bioanalytical method for the quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, and ribociclib in human and mouse matrices using liquid chromatography-tandem mass spectrometry.
Martínez-Chávez A; Rosing H; Hillebrand M; Tibben M; Schinkel AH; Beijnen JH
Anal Bioanal Chem; 2019 Aug; 411(20):5331-5345. PubMed ID: 31209549
[TBL] [Abstract][Full Text] [Related]
5. ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites.
Martínez-Chávez A; Loos NHC; Lebre MC; Tibben MM; Rosing H; Beijnen JH; Schinkel AH
Pharmacol Res; 2022 Apr; 178():105954. PubMed ID: 34700018
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Quantitative LC-MS/MS Method for CDK4/6 Inhibitors Palbociclib, Ribociclib, Abemaciclib, and Abemaciclib-M2 in Human Plasma.
Burke SM; Kamal M; Goey AKL
Ther Drug Monit; 2023 Jun; 45(3):327-336. PubMed ID: 36728357
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Monitoring of Palbociclib, Ribociclib, Abemaciclib, M2, M20, and Letrozole in Human Plasma: A Novel LC-MS/MS Method.
Posocco B; Zanchetta M; Orleni M; Gagno S; Montico M; Peruzzi E; Roncato R; Gerratana L; Corsetti S; Puglisi F; Toffoli G
Ther Drug Monit; 2024 Feb; ():. PubMed ID: 38366332
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous determination of LY3214996, abemaciclib, and M2 and M20 metabolites in human plasma, cerebrospinal fluid, and brain tumor by LC-MS/MS.
Margaryan T; Elliott M; Sanai N; Tovmasyan A
J Pharm Anal; 2022 Aug; 12(4):601-609. PubMed ID: 36105156
[TBL] [Abstract][Full Text] [Related]
9. Effects of
Maeda A; Ando H; Irie K; Hashimoto N; Morishige JI; Fukushima S; Ebi H; Uchida K; Iwata H; Sawaki M
Anticancer Res; 2023 Mar; 43(3):1283-1289. PubMed ID: 36854511
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of abemaciclib and letrozole in rat plasma: method development, validation and pharmacokinetic application.
Dhakne P; Sahu AK; Sharma MK; Sengupta P
Biomed Chromatogr; 2020 Jun; 34(6):e4825. PubMed ID: 32166756
[TBL] [Abstract][Full Text] [Related]
11. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an LC-MS/MS method for the quantitative analysis of milciclib in human and mouse plasma, mouse tissue homogenates and tissue culture medium.
Martínez-Chávez A; Tibben MM; Broeders J; Rosing H; Schinkel AH; Beijnen JH
J Pharm Biomed Anal; 2020 Oct; 190():113516. PubMed ID: 32784092
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
Liu C; Lu Y; Sun H; Yang J; Liu Y; Lai X; Gong Y; Liu X; Li Y; Zhang Y; Chen X; Zhong D
J Pharm Biomed Anal; 2018 Feb; 149():394-402. PubMed ID: 29154109
[TBL] [Abstract][Full Text] [Related]
14. A convenient UHPLC-MS/MS method for routine monitoring of plasma and brain levels of nicotine and cotinine as a tool to validate newly developed preclinical smoking model in mouse.
Kaisar MA; Kallem RR; Sajja RK; Sifat AE; Cucullo L
BMC Neurosci; 2017 Oct; 18(1):71. PubMed ID: 29020944
[TBL] [Abstract][Full Text] [Related]
15. An UHPLC-MS/MS method for quantification of the CDK4/6 inhibitor abemaciclib in human serum.
Habler K; Vogeser M; Teupser D
J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():15-21. PubMed ID: 35199096
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma.
Lin L; Gao Z; Chen X; Zhong D
J Pharm Biomed Anal; 2013 Dec; 86():49-55. PubMed ID: 23973791
[TBL] [Abstract][Full Text] [Related]
17. Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling.
Posada MM; Morse BL; Turner PK; Kulanthaivel P; Hall SD; Dickinson GL
J Clin Pharmacol; 2020 Jul; 60(7):915-930. PubMed ID: 32080863
[TBL] [Abstract][Full Text] [Related]
18. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
19. A novel LC-MS/MS method for the simultaneous quantification of topiramate and its main metabolites in human plasma.
Milosheska D; Roškar R
J Pharm Biomed Anal; 2017 May; 138():180-188. PubMed ID: 28214451
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a UPLC-MS/MS method with a broad linear dynamic range for the quantification of morphine, morphine-3-glucuronide and morphine-6-glucuronide in mouse plasma and tissue homogenates.
Heydari P; Martins MLF; Rosing H; Hillebrand MJX; Gebretensae A; Schinkel AH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122403. PubMed ID: 33246879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
